{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T11:04:47Z","timestamp":1793271887270,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["23AA2003"],"award-info":[{"award-number":["23AA2003"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"DOI":"10.1007\/s11657-025-01582-9","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:27:22Z","timestamp":1752593242000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between ramelteon use and risk of fragility fractures: A retrospective cohort study"],"prefix":"10.1007","volume":"20","author":[{"given":"Hitoshi","family":"Tange","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihisa","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Sasabuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Yasunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"1582_CR1","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s00198-021-05900-y","volume":"33","author":"MS LeBoff","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL et al (2022) The clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 33:2049\u20132102. https:\/\/doi.org\/10.1007\/s00198-021-05900-y","journal-title":"Osteoporos Int"},{"key":"1582_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s00198-020-05294-3","volume":"31","author":"RL Barron","year":"2020","unstructured":"Barron RL, Oster G, Grauer A, Crittenden DB, Weycker D (2020) Determinants of imminent fracture risk in postmenopausal women with osteoporosis. Osteoporos Int 31:2103\u20132111. https:\/\/doi.org\/10.1007\/s00198-020-05294-3","journal-title":"Osteoporos Int"},{"key":"1582_CR3","doi-asserted-by":"publisher","unstructured":"Arceo-Mendoza RM, Camacho P (2015) Prediction of fracture risk in patients with osteoporosis: A brief review. Womens Health (Lond) 11:477\u2013482; quiz 483\u2013484. https:\/\/doi.org\/10.2217\/whe.15.14","DOI":"10.2217\/whe.15.14"},{"key":"1582_CR4","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00198-006-0137-7","volume":"17","author":"AH Holmberg","year":"2006","unstructured":"Holmberg AH, Johnell O, Nilsson PM et al (2006) Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int 17:1065\u20131077. https:\/\/doi.org\/10.1007\/s00198-006-0137-7","journal-title":"Osteoporos Int"},{"key":"1582_CR5","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1007\/s001980070075","volume":"11","author":"JA Cauley","year":"2000","unstructured":"Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556\u2013561. https:\/\/doi.org\/10.1007\/s001980070075","journal-title":"Osteoporos Int"},{"key":"1582_CR6","doi-asserted-by":"crossref","unstructured":"Veronese N, Kolk H, Maggi S (2021) Epidemiology of fragility fractures and social impact. In: Orthogeriatrics: The management of older patients with fragility fractures, 2nd edn. Falaschi P, Marsh D (eds). Springer, Cham, CH","DOI":"10.1007\/978-3-030-48126-1_2"},{"key":"1582_CR7","doi-asserted-by":"publisher","first-page":"e12548","DOI":"10.1111\/jpi.12548","volume":"66","author":"T Li","year":"2019","unstructured":"Li T, Jiang S, Lu C et al (2019) Melatonin: Another avenue for treating osteoporosis? J Pineal Res 66:e12548. https:\/\/doi.org\/10.1111\/jpi.12548","journal-title":"J Pineal Res"},{"key":"1582_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1111\/jpi.12116","volume":"56","author":"S Maria","year":"2014","unstructured":"Maria S, Witt-Enderby PA (2014) Melatonin effects on bone: Potential use for the prevention and treatment for osteopenia, osteoporosis, and periodontal disease and for use in bone-grafting procedures. J Pineal Res 56:115\u2013125. https:\/\/doi.org\/10.1111\/jpi.12116","journal-title":"J Pineal Res"},{"key":"1582_CR9","doi-asserted-by":"publisher","first-page":"e12423","DOI":"10.1111\/jpi.12423","volume":"63","author":"K Sharan","year":"2017","unstructured":"Sharan K, Lewis K, Furukawa T, Yadav VK (2017) Regulation of bone mass through pineal-derived melatonin-MT2 receptor pathway. J Pineal Res 63:e12423. https:\/\/doi.org\/10.1111\/jpi.12423","journal-title":"J Pineal Res"},{"key":"1582_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1359\/jbmr.2002.17.7.1219","volume":"17","author":"H Koyama","year":"2002","unstructured":"Koyama H, Nakade O, Takada Y, Kaku T, Lau KHW (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17:1219\u20131229. https:\/\/doi.org\/10.1359\/jbmr.2002.17.7.1219","journal-title":"J Bone Miner Res"},{"key":"1582_CR11","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.3390\/ijms18061142","volume":"18","author":"HJ Kim","year":"2017","unstructured":"Kim HJ, Kim HJ, Bae M-K, Kim Y-D (2017) Suppression of osteoclastogenesis by melatonin: A melatonin receptor-independent action. Int J Mol Sci 18:1142. https:\/\/doi.org\/10.3390\/ijms18061142","journal-title":"Int J Mol Sci"},{"key":"1582_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1111\/j.1600-079X.2011.00956.x","volume":"52","author":"MP Kotlarczyk","year":"2012","unstructured":"Kotlarczyk MP, Lassila HC, O\u2019Neil CK et al (2012) Melatonin osteoporosis prevention study (MOPS): A randomized, double-blind, placebo-controlled study examining the effects of melatonin on bone health and quality of life in perimenopausal women. J Pineal Res 52:414\u2013426. https:\/\/doi.org\/10.1111\/j.1600-079X.2011.00956.x","journal-title":"J Pineal Res"},{"key":"1582_CR13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/jpi.12252","volume":"59","author":"AK Amstrup","year":"2015","unstructured":"Amstrup AK, Sikjaer T, Heickendorff L, Mosekilde L, Rejnmark L (2015) Melatonin improves bone mineral density at the femoral neck in postmenopausal women with osteopenia: A randomized controlled trial. J Pineal Res 59:221\u2013229. https:\/\/doi.org\/10.1111\/jpi.12252","journal-title":"J Pineal Res"},{"key":"1582_CR14","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ageing\/afw123","volume":"45","author":"M Frisher","year":"2016","unstructured":"Frisher M, Gibbons N, Bashford J, Chapman S, Weich S (2016) Melatonin, hypnotics and their association with fracture: A matched cohort study. Age Ageing 45:801\u2013806. https:\/\/doi.org\/10.1093\/ageing\/afw123","journal-title":"Age Ageing"},{"key":"1582_CR15","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1007\/s00198-023-06740-8","volume":"34","author":"T Yang","year":"2023","unstructured":"Yang T, Wu J, Ding X, Zhou B, Xiong Y (2023) The association of melatonin use and hip fracture: A matched cohort study. Osteoporos Int 34:1127\u20131135. https:\/\/doi.org\/10.1007\/s00198-023-06740-8","journal-title":"Osteoporos Int"},{"key":"1582_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1755-5949.2008.00066.x","volume":"15","author":"M Miyamoto","year":"2009","unstructured":"Miyamoto M (2009) Pharmacology of ramelteon, a selective MT1\/MT2 receptor agonist: A novel therapeutic drug for sleep disorders. CNS Neurosci Ther 15:32\u201351. https:\/\/doi.org\/10.1111\/j.1755-5949.2008.00066.x","journal-title":"CNS Neurosci Ther"},{"key":"1582_CR17","doi-asserted-by":"publisher","first-page":"173577","DOI":"10.1016\/j.ejphar.2020.173577","volume":"887","author":"D K\u00f6se","year":"2020","unstructured":"K\u00f6se D, K\u00f6se A, Hal\u0131c\u0131 Z et al (2020) Do peripheral melatonin agonists improve bone fracture healing? The effects of agomelatine and ramelteon on experimental bone fracture. Eur J Pharmacol 887:173577. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173577","journal-title":"Eur J Pharmacol"},{"key":"1582_CR18","doi-asserted-by":"publisher","first-page":"e70048","DOI":"10.1002\/pds.70048","volume":"33","author":"QL Her","year":"2024","unstructured":"Her QL, Rouette J, Young JC, Webster-Clark M, Tazare J (2024) Core concepts in pharmacoepidemiology: New-user designs. Pharmacoepidemiol Drug Saf 33:e70048. https:\/\/doi.org\/10.1002\/pds.70048","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"1582_CR19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jpsychires.2024.06.029","volume":"176","author":"G Pan","year":"2024","unstructured":"Pan G, Ni L, Yan H, Yao L (2024) Association between the use of orexin receptor antagonists and falls or fractures: A meta-analysis. J Psychiatr Res 176:393\u2013402. https:\/\/doi.org\/10.1016\/j.jpsychires.2024.06.029","journal-title":"J Psychiatr Res"},{"key":"1582_CR20","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1007\/s00198-016-3605-8","volume":"27","author":"SM Park","year":"2016","unstructured":"Park SM, Ryu J, Lee DR et al (2016) Zolpidem use and risk of fractures: A systematic review and meta-analysis. Osteoporos Int 27:2935\u20132944. https:\/\/doi.org\/10.1007\/s00198-016-3605-8","journal-title":"Osteoporos Int"},{"key":"1582_CR21","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1093\/ageing\/afx167","volume":"47","author":"N Treves","year":"2018","unstructured":"Treves N, Perlman A, Kolenberg Geron L, Asaly A, Matok I (2018) Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis. Age Ageing 47:201\u2013208. https:\/\/doi.org\/10.1093\/ageing\/afx167","journal-title":"Age Ageing"},{"key":"1582_CR22","doi-asserted-by":"publisher","first-page":"101866","DOI":"10.1016\/j.smrv.2023.101866","volume":"73","author":"C Xu","year":"2024","unstructured":"Xu C, Leung JCN, Shi J, Lum DH, Lai FTT (2024) Sedative-hypnotics and osteoporotic fractures: A systematic review of observational studies with over six million individuals. Sleep Med Rev 73:101866. https:\/\/doi.org\/10.1016\/j.smrv.2023.101866","journal-title":"Sleep Med Rev"},{"key":"1582_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jbspin.2019.11.003","volume":"87","author":"TN Poly","year":"2020","unstructured":"Poly TN, Islam MM, Yang H-C, Li YJ (2020) Association between benzodiazepines use and risk of hip fracture in the elderly people: A meta-analysis of observational studies. Joint Bone Spine 87:241\u2013249. https:\/\/doi.org\/10.1016\/j.jbspin.2019.11.003","journal-title":"Joint Bone Spine"},{"key":"1582_CR24","doi-asserted-by":"publisher","first-page":"e0238723","DOI":"10.1371\/journal.pone.0238723","volume":"15","author":"Y Ishibashi","year":"2020","unstructured":"Ishibashi Y, Nishitani R, Shimura A et al (2020) Non-GABA sleep medications, suvorexant as risk factors for falls: Case-control and case-crossover study. PLoS ONE 15:e0238723. https:\/\/doi.org\/10.1371\/journal.pone.0238723","journal-title":"PLoS ONE"},{"key":"1582_CR25","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1248\/bpb.b19-00684","volume":"43","author":"H Torii","year":"2020","unstructured":"Torii H, Ando M, Tomita H et al (2020) Association of hypnotic drug use with fall incidents in hospitalized elderly patients: A case-crossover study. Biol Pharm Bull 43:925\u2013931. https:\/\/doi.org\/10.1248\/bpb.b19-00684","journal-title":"Biol Pharm Bull"},{"key":"1582_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/jcpt.13619","volume":"47","author":"R Sogawa","year":"2022","unstructured":"Sogawa R, Emoto A, Monji A et al (2022) Association of orexin receptor antagonists with falls during hospitalization. J Clin Pharm Ther 47:809\u2013813. https:\/\/doi.org\/10.1111\/jcpt.13619","journal-title":"J Clin Pharm Ther"},{"key":"1582_CR27","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2147\/IJGM.S452278","volume":"17","author":"R Hirata","year":"2024","unstructured":"Hirata R, Katsuki NE, Shimada H et al (2024) The administration of lemborexant at admission is not associated with inpatient falls: A multicenter retrospective observational study. Int J Gen Med 17:1139\u20131144. https:\/\/doi.org\/10.2147\/IJGM.S452278","journal-title":"Int J Gen Med"},{"key":"1582_CR28","doi-asserted-by":"publisher","unstructured":"Yasunaga H (2025) DeSC database. Ann Clin Epidemiol 7:46\u201349. https:\/\/doi.org\/10.37737\/ace.25006","DOI":"10.37737\/ace.25006"},{"key":"1582_CR29","doi-asserted-by":"publisher","unstructured":"Okada A, Yasunaga H (2022) Prevalence of noncommunicable diseases in Japan using a newly developed administrative claims database covering Young, middle-aged, and elderly people. JMA 5:190\u2013198. https:\/\/doi.org\/10.31662\/jmaj.2021-0189","DOI":"10.31662\/jmaj.2021-0189"},{"key":"1582_CR30","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2337\/dc17-2004","volume":"41","author":"Y Komorita","year":"2018","unstructured":"Komorita Y, Iwase M, Fujii H et al (2018) Impact of body weight loss from maximum weight on fragility bone fractures in Japanese patients with type 2 diabetes: The Fukuoka diabetes registry. Diabetes Care 41:1061\u20131067. https:\/\/doi.org\/10.2337\/dc17-2004","journal-title":"Diabetes Care"},{"key":"1582_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jgs.18068","volume":"71","author":"M Adomi","year":"2023","unstructured":"Adomi M, Maeda M, Murata F, Fukuda H (2023) Comparative risk of fracture in community-dwelling older adults initiating suvorexant versus Z-drugs: Results from LIFE study. J Am Geriatr Soc 71:109\u2013120. https:\/\/doi.org\/10.1111\/jgs.18068","journal-title":"J Am Geriatr Soc"},{"key":"1582_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11657-016-0280-5","volume":"11","author":"M Bonafede","year":"2016","unstructured":"Bonafede M, Shi N, Barron R et al (2016) Predicting imminent risk for fracture in patients aged 50 or older with osteoporosis using US claims data. Arch Osteoporos 11:26. https:\/\/doi.org\/10.1007\/s11657-016-0280-5","journal-title":"Arch Osteoporos"},{"key":"1582_CR33","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1007\/s00198-016-3646-z","volume":"27","author":"A Balasubramanian","year":"2016","unstructured":"Balasubramanian A, Wade SW, Adler RA et al (2016) Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis. Osteoporos Int 27:3239\u20133249. https:\/\/doi.org\/10.1007\/s00198-016-3646-z","journal-title":"Osteoporos Int"},{"key":"1582_CR34","doi-asserted-by":"publisher","unstructured":"Okada A, Honda A, Watanabe H et al (2024) Proteinuria screening and risk of bone fracture: A retrospective cohort study using a nationwide population-based database. Clin Kidney J 17:sfad302. https:\/\/doi.org\/10.1093\/ckj\/sfad302","DOI":"10.1093\/ckj\/sfad302"},{"key":"1582_CR35","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/aje\/kwy201","volume":"188","author":"F Li","year":"2019","unstructured":"Li F, Thomas LE, Li F (2019) Addressing extreme propensity scores via the overlap weights. Am J Epidemiol 188:250\u2013257. https:\/\/doi.org\/10.1093\/aje\/kwy201","journal-title":"Am J Epidemiol"},{"key":"1582_CR36","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/aje\/kwac043","volume":"191","author":"C Cheng","year":"2022","unstructured":"Cheng C, Li F, Thomas LE, Li FF (2022) Addressing extreme propensity scores in estimating counterfactual survival functions via the overlap weights. Am J Epidemiol 191:1140\u20131151. https:\/\/doi.org\/10.1093\/aje\/kwac043","journal-title":"Am J Epidemiol"},{"key":"1582_CR37","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1111\/ggi.14600","volume":"23","author":"S Matsumoto","year":"2023","unstructured":"Matsumoto S, Tamiya H, Yamana H et al (2023) Association between the type of hypnotic drug and in-hospital fractures in older patients with neurocognitive disorders: A case-control study using a nationwide database. Geriatr Gerontol Int 23:500\u2013505. https:\/\/doi.org\/10.1111\/ggi.14600","journal-title":"Geriatr Gerontol Int"},{"key":"1582_CR38","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00198-012-2210-8","volume":"24","author":"JT Schousboe","year":"2013","unstructured":"Schousboe JT, Paudel ML, Taylor BC et al (2013) Magnitude and consequences of misclassification of incident hip fractures in large cohort studies: The Study of Osteoporotic Fractures and Medicare claims data. Osteoporos Int 24:801\u2013810. https:\/\/doi.org\/10.1007\/s00198-012-2210-8","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01582-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-025-01582-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-025-01582-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:17:23Z","timestamp":1766524643000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-025-01582-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1582"],"URL":"https:\/\/doi.org\/10.1007\/s11657-025-01582-9","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of The University of Tokyo [approval number: 2021010NI (April 23rd, 2021)] and followed the guidelines established in the Declaration of Helsinki. As all data were de-identified, the requirement for patient informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Yoshihisa Miyamoto and Yusuke Sasabuchi have an academic affiliation with the Department of Real-world Evidence, which is a cooperative program between The University of Tokyo and DeSC Healthcare.Hitoshi Tange and Hideo Yasunaga declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"95"}}